Skip to main content

Waiting on Wednesday

Waiting on Wednesday is a weekly meme hosted over at Breaking the Spine.







Title: Unrest
Author: Wendy Higgins
Series: Unknown #2
Genre: New Adult Science Fiction
Expected Publication: February 16th 2017
Publisher: Self published by Wendy Higgins


Blurb 
Being on the run in the desert means food and sanctuary are hard to come by, but Amber Tate and her crew are not about to give up. Not after having so many of the things they love brutally ripped from them by an unknown enemy who sent their world into the apocalypse.

Survival takes precedence, but once safe shelter is found, their guards fall and the emotions they’ve been holding in are finally released. Anger, insecurities...lust. In their tight quarters, Amber, Rylen, Tater, and Remy can't escape it. The past must be faced, and passions run even stronger in the darkest of times.

In the midst of unrest, their worlds are rocked again when they discover the truth about the war that’s ruined their lives. They thought finding out the enemy's identity would give them the edge; instead it’s revealed terrifying dangers they never thought possible. 

Popular posts from this blog

(Pride) Book Review - Sagittarius Saves Libra

True love is on the horizon, Sagittarius. It’s a good time to step out of your routine and into the unknown. Jason Lyall wants someone to come home to, someone he can be his most ridiculous self with. Someone who loves him regardless. But no matter how hard he tries, he can never quite make that connection, and now his last girlfriend has moved on—she’s engaged. So when his identical twin begs him to swap lives for a few weeks, Jason can see the appeal. Suddenly he’s living another life in a tiny Australian town, contending with weird, wild, and wonderful things the likes of which he’s never encountered before. Like spiders. Like snakes. Like his new neighbour, Sergeant Owen Stirling, who is all kinds of . . . suspicious. Prepare to be caught in a merry mix-up, Libra. It’s a dance of side-stepping and seduction. Book Breakdown I did not know this was coming! When I woke up on June 1st and saw an email from Amazon saying the author dropped a new book in this series... I lost it! I hones

Short Update + The Stand-In Book Review

I've been lurking around your blogs for a few hours today and trying to catch up but I doubt I will. I've just missed so much! Sorry!  Today, I'm feeling a little bit better so I thought I would update you guys, since I've not blogged any in two weeks. The posts you've seen since then are just ones that I had scheduled for a while. I'm on the hunt for an anxiety medicine and had a really bad reaction to one my doctor put me on. I'm currently on steroids for a week to help that reaction.  Also, my grandma passed away recently and I've been trying to deal with that and help my family. They are really having it rough right now and it's been killing me trying to help them.  Then there's stuff with my kiddo. So yeah, I've been gone for a bit and dealing with things. I'm really hoping to get straightened out and get back to normal because this has been a sucky time.  Onto something bookish! I did manage to finish a book before everything kinda

Bad Blood: Secrets and Lies in a Silicon Valley Startup - Review

The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions,